Topographical Analysis of the Choriocapillaris Reperfusion After Loading Anti-VEGF Therapy in Neovascular AMD

被引:20
|
作者
Viggiano, Pasquale [1 ]
Grassi, Maria Oliva [1 ]
Pignataro, Mariagrazia [1 ]
Boscia, Giacomo [3 ]
Borrelli, Enrico [2 ]
Molfetta, Teresa [1 ]
Evangelista, Federica [4 ]
Alessio, Giovanni [1 ]
Boscia, Francesco [1 ]
机构
[1] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
[2] San Raffaele Univ Hosp, Dept Ophthalmol, Milan, Italy
[3] Univ Turin, Dept Surg Sci, Ophthalmol Unit, AOU City Hlth & Sci Turin, Turin, Italy
[4] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy
来源
关键词
age-related macular degeneration (AMD); neovascular age-related macular degeneration (nAMD); optical coherence tomography (OCT); retinal disease; COHERENCE TOMOGRAPHY ANGIOGRAPHY; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; FLOW; RANIBIZUMAB; THICKNESS; INJECTION; EYES;
D O I
10.1167/tvst.11.9.18
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The purpose of this study was to evaluate choriocapillaris vascular density changes around macular neovascularization (MNV) before and after anti-vascular endothelium growth factor (VEGF) injections by optical coherence tomography angiography (OCTA). Methods: Treatment-naive eyes with a diagnosis of exudative AMD and type 1 MNV were included. En face optical coherence tomography angiograms were analyzed for percentage of choriocapillaris (CC) flow deficit percentage (FD%), the FD average area (FDa), and the FD number (FDn) in 5 progressive 200-mu m-wide concentric rings (R1, R2, R3, R4, and R5) surrounding the dark halo around the MNV. The OCTA acquisition was performed at the following visits: (i) before the loading phase of intravitreal injection of aflibercept or ranibizumab (T1), and (ii) 1 month after the last intravitreal injection of loading phase comprising 3 monthly injections (T2). Results: A total of 30 eyes of 30 Caucasian patients with treatment naive neurovascular AMD (nAMD) were included in the study. All rings showed a progressive FD% reduction at T2 in comparison to T1 values indicating gradual CC reperfusion of the peripheral rings. Furthermore, we found a progressive contraction of the FD average area in all the rings considered (P < 0.05). On the other hand, at T2, a significant increase in the FD number of the 5 rings was displayed, as compared to T1 (P < 0.05). Conclusions: Our analysis showed topographical CC reperfusion after loading anti-VEGF therapy. CC flow deficits were greater around the associated dark halo before treatment, followed by a progressive recovery of CC flow after intravitreal therapy. Translational Relevance: OCTA may be used to assess the development and progression of MNV but also in assessing response to intravitreal injections of anti-VEGF.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Intravitreal anti-VEGF therapy with bevacizumab for neovascular AMD
    Schaal, K. B.
    Engler, C.
    Schuett, F.
    Scheuerle, A.
    Dithmar, S.
    OPHTHALMOLOGE, 2008, 105 (06): : 538 - +
  • [2] Neovascular Morphology by ICG Angiography and Response to Loading-Dose Anti-VEGF Therapy in Patients with Neovascular AMD
    Mettu, Priyatham S.
    Allingham, Michael J.
    Nicholas, Peter C.
    Cousins, Scott W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [3] Association of fluid recurrence with visual maintenance following the loading phase in anti-VEGF therapy for neovascular AMD
    Waldstein, Sebastian M.
    Chong, Victor
    Larsen, Michael
    Warburton, James
    Weichselberger, Andreas
    Wright, Jnathan
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Defining response to anti-VEGF therapies in neovascular AMD
    W M Amoaku
    U Chakravarthy
    R Gale
    M Gavin
    F Ghanchi
    J Gibson
    S Harding
    R L Johnston
    S Kelly
    A Lotery
    S Mahmood
    G Menon
    S Sivaprasad
    J Talks
    A Tufail
    Y Yang
    Eye, 2015, 29 : 721 - 731
  • [5] Defining response to anti-VEGF therapies in neovascular AMD
    Amoaku, W. M.
    Chakravarthy, U.
    Gale, R.
    Gavin, M.
    Ghanchi, F.
    Gibson, J.
    Harding, S.
    Johnston, R. L.
    Kelly, S.
    Lotery, A.
    Mahmood, S.
    Menon, G.
    Sivaprasad, S.
    Talks, J.
    Tufail, A.
    Yang, Y.
    EYE, 2015, 29 (06) : 721 - 731
  • [6] Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
    Fassnacht-Riederle, Heidi
    Becker, Matthias
    Graf, Nicole
    Michels, Stephan
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (11) : 1705 - 1709
  • [7] Neovascular AMD With Marked Macular Fluid and Rapid Response to Anti-VEGF Therapy
    Wood, Edward
    Chang, Jonathan S.
    Flynn, Harry W., Jr.
    Kitchens, John W.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2014, 45 (02) : 175 - 178
  • [8] Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
    Heidi Fassnacht-Riederle
    Matthias Becker
    Nicole Graf
    Stephan Michels
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 1705 - 1709
  • [9] Anti-VEGF resistance in neovascular AMD: Role of PDGF antagonism
    Dugel, Pravin U.
    Kunimoto, Derek
    Quinlan, Edward
    Jamal, Karim
    Goldenberg, David
    Mehta, Sachin
    Witmer, Matthew
    Barakat, Mark
    Hakimbashi, Milad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Phacoemulsification in eyes with neovascular AMD treated with anti-VEGF injections
    Muzyka-Wozniak, Maria
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2011, 21 (06) : 766 - 770